Deconstructing the Future of Management: Pharmakon, Gary Hamel and the Impossibility of Invention

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

There has been a growing tendency to argue that the practice of management must be reinvented in the future in order to energize the creative potential of employees. However, the discourse on ‘management innovation’ attributes a curious dual function to the concept of management. On the one hand, management is portrayed as the ‘toxin’ that can impede innovation. But on the other hand, management is portrayed the ‘cure’ that will heal the defects that prevents innovation. Informed by Derrida's reflection upon the dual meaning of pharmakon, a word that means both ‘remedy’ and ‘poison’, the paper engages with Hamel's popular management handbook The Future of Management. Although Hamel attempts to establish a clear-cut distinction between those principles of management that obstruct and those that facilitate innovation, one is ultimately left uncertain whether management is a cure or a poison for innovation. This ambivalence points to an underlying paradox of contemporary post-managerial thinking that is characterized by incorporating transgression into its productive logic.
Original languageEnglish
JournalFutures The journal of policy, planning and futures studies
Volume68
Pages (from-to)57-66
Number of pages10
ISSN0016-3287
DOIs
Publication statusPublished - Apr 2015

Cite this

@article{506ae9af3afd4a748415220caa076b39,
title = "Deconstructing the Future of Management: Pharmakon, Gary Hamel and the Impossibility of Invention",
abstract = "There has been a growing tendency to argue that the practice of management must be reinvented in the future in order to energize the creative potential of employees. However, the discourse on ‘management innovation’ attributes a curious dual function to the concept of management. On the one hand, management is portrayed as the ‘toxin’ that can impede innovation. But on the other hand, management is portrayed the ‘cure’ that will heal the defects that prevents innovation. Informed by Derrida's reflection upon the dual meaning of pharmakon, a word that means both ‘remedy’ and ‘poison’, the paper engages with Hamel's popular management handbook The Future of Management. Although Hamel attempts to establish a clear-cut distinction between those principles of management that obstruct and those that facilitate innovation, one is ultimately left uncertain whether management is a cure or a poison for innovation. This ambivalence points to an underlying paradox of contemporary post-managerial thinking that is characterized by incorporating transgression into its productive logic.",
keywords = "Management innovation, Management gurus, Gary Hamel, Deconstruction, Jacques Derrida",
author = "Johnsen, {Christian Garmann}",
year = "2015",
month = "4",
doi = "10.1016/j.futures.2014.05.007",
language = "English",
volume = "68",
pages = "57--66",
journal = "Futures The journal of policy, planning and futures studies",
issn = "0016-3287",
publisher = "Pergamon Press",

}

Deconstructing the Future of Management : Pharmakon, Gary Hamel and the Impossibility of Invention. / Johnsen, Christian Garmann.

In: Futures The journal of policy, planning and futures studies, Vol. 68, 04.2015, p. 57-66.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Deconstructing the Future of Management

T2 - Pharmakon, Gary Hamel and the Impossibility of Invention

AU - Johnsen, Christian Garmann

PY - 2015/4

Y1 - 2015/4

N2 - There has been a growing tendency to argue that the practice of management must be reinvented in the future in order to energize the creative potential of employees. However, the discourse on ‘management innovation’ attributes a curious dual function to the concept of management. On the one hand, management is portrayed as the ‘toxin’ that can impede innovation. But on the other hand, management is portrayed the ‘cure’ that will heal the defects that prevents innovation. Informed by Derrida's reflection upon the dual meaning of pharmakon, a word that means both ‘remedy’ and ‘poison’, the paper engages with Hamel's popular management handbook The Future of Management. Although Hamel attempts to establish a clear-cut distinction between those principles of management that obstruct and those that facilitate innovation, one is ultimately left uncertain whether management is a cure or a poison for innovation. This ambivalence points to an underlying paradox of contemporary post-managerial thinking that is characterized by incorporating transgression into its productive logic.

AB - There has been a growing tendency to argue that the practice of management must be reinvented in the future in order to energize the creative potential of employees. However, the discourse on ‘management innovation’ attributes a curious dual function to the concept of management. On the one hand, management is portrayed as the ‘toxin’ that can impede innovation. But on the other hand, management is portrayed the ‘cure’ that will heal the defects that prevents innovation. Informed by Derrida's reflection upon the dual meaning of pharmakon, a word that means both ‘remedy’ and ‘poison’, the paper engages with Hamel's popular management handbook The Future of Management. Although Hamel attempts to establish a clear-cut distinction between those principles of management that obstruct and those that facilitate innovation, one is ultimately left uncertain whether management is a cure or a poison for innovation. This ambivalence points to an underlying paradox of contemporary post-managerial thinking that is characterized by incorporating transgression into its productive logic.

KW - Management innovation

KW - Management gurus

KW - Gary Hamel

KW - Deconstruction

KW - Jacques Derrida

U2 - 10.1016/j.futures.2014.05.007

DO - 10.1016/j.futures.2014.05.007

M3 - Journal article

VL - 68

SP - 57

EP - 66

JO - Futures The journal of policy, planning and futures studies

JF - Futures The journal of policy, planning and futures studies

SN - 0016-3287

ER -